Calyx and artificial intelligence (AI) neuroimaging technology firm Qynapse plan to collaborate on making Qynapse's QyScore and QyPredict algorithms available to customers developing medical treatments for central nervous system disorders.
QyScore and QyPredict help clinicians analyze and interpret brain scans, helping them determine the best treatment for conditions such as multiple sclerosis, Parkinson's, Alzheimer's, and Huntington's diseases, Calyx said.
